<DOC>
	<DOCNO>NCT00555880</DOCNO>
	<brief_summary>The purpose clinical study evaluate clinical effect midodrine hydrochloride ( ProAmatineÂ® ) compare placebo patient orthostatic hypotension measure time onset near syncopal symptom assess several cardiovascular measurement , heart rate , blood pressure , ECG , use tilt table test .</brief_summary>
	<brief_title>Study Assess Benefit Midodrine Treatment Patients With Neurogenic Orthostatic Hypotension</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Hypotension , Orthostatic</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>The male female subject must 18 year age old ambulatory . ( Subjects must require assistance walker wheelchair perform regular daily activity time . ) Women childbearing potential must negative serum beta HCG pregnancy test screen baseline . The subject diagnose symptomatic orthostatic hypotension due Parkinson 's disease , multiple system atrophy , pure autonomic failure autonomic neuropathy ( i.e . neurogenic orthostatic hypotension ) . The subject manifest one following symptom stand history one following treat orthostatic hypotension : dizziness , lightheadedness , feel faint feeling like may black . The subject willing able undergo procedure require protocol include morning office visit , assessment completion , protocol compliance participation washout period . The subject sign InstitutionalReviewBoard approve write informed consent form prior study procedure take place . The subject pregnant lactate female . The subject preexisting sustain supine hypertension great 180 mm Hg systolic 110 mm Hg diastolic . The subject take medication vasodilator , pressor , diuretic , ACE inhibitor , angiotensin receptor blocker , betablockers , combine alpha betablockers , MAOI 's , herbal specific mixed effect medication . The Principal Investigator deem laboratory test abnormality clinical significant . The subject diagnosis follow disorder time screening : pheochromocytoma ; cardiac condition include : congestive heart failure within previous 6 month , myocardial infarction within previous 6 month , symptomatic coronary artery disease , history ventricular tachycardia , uncontrolled cardiac arrhythmia ; thyrotoxicosis ; uncontrolled diabetes mellitus ( uncontrolled define HgbA1c great equal 10 % ) ; history cerebrovascular accident , transient ischemic attack ( TIA ) symptomatic carotid artery stenosis within previous 6 month ; history coagulopathies ; pulmonary hypertension ; severe psychiatric disorder ; renal failure ( Creatinine equal great 2 time upper limit normal ) The subject concurrent chronic acute illness , disability , condition might confound result test and/or measurement administer trial , might increase risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>